Latest Regulatory Approvals News

Audalia Resources has completed critical drilling programs at its Medcalf vanadium-titanium-iron project, progressing resource upgrades and mine design while managing tight cash reserves and financing arrangements.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Manuka Resources has declared a maiden Probable Ore Reserve of 39,000 ounces of gold at its historic Mt Boppy Open Pit, underpinning a cutback project that adds significant value to its Cobar Basin production plan.

VHM Limited has secured a crucial mining licence for its Goschen Rare Earths and Mineral Sands Project, alongside key domestic and international partnerships and a successful $8.6 million capital raise.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

Cavalier Resources progresses its Crawford Gold Project with key milestones including an $11 million stream finance negotiation with Raptor Capital and the appointment of Colin Bald as General Manager of Operations.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Tigers Realm Coal’s planned sale of its Russian subsidiaries faces significant delays and a pricing impasse, with regulatory hurdles and sanctions complicating the exit process and triggering an ASX trading suspension.

Terramin Australia reports steady progress across multiple projects including key drilling at Tala Hamza and regulatory approvals at Kapunda, while navigating legal challenges at Bird in Hand. Algeria’s recent mining reforms offer a promising backdrop for the company’s expansion plans.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Wildcat Resources has completed a positive Preliminary Feasibility Study for its Tabba Tabba lithium project in Western Australia, confirming a long-life mine with strong financial metrics and a clear path to development.